Abnormal tau protein folding has been thought to lead to cytotoxic tau aggregation, accumulation of insoluble tau deposits, and subsequent neuronal loss that correlates with the clinical features of tauopathies during life in clinical-autopsy and clinical–tau PET studies (13, 14). This evidence concerns the gene MAPT and tauopathy.